| ID | Sequence | Length | GC content |
|---|---|---|---|
| lnc-FOXD4L5-25:4 | AGUGAGGUCGGCGCCCGCCAGUAACAAACAUGGCUCCCUGAAGCCGCUC… | 1029 nt | 0.5413 |
| lnc-FOXD4L5-25:5 | AGUGAGGUCGGCGCCCGCCAGUAACAAACAUGGCUCCCUGAAGCCGCUC… | 1602 nt | 0.4813 |
| lnc-FOXD4L5-25:6 | AGUGAGGUCGGCGCCCGCCAGUAACAAACAUGGCUCCCUGAAGCCGCUC… | 1448 nt | 0.5166 |
| lnc-FOXD4L5-25:7 | AGUGAGGUCGGCGCCCGCCAGUAACAAACAUGGCUCCCUGAAGCCGCUC… | 1028 nt | 0.5418 |
| lnc-FOXD4L5-25:8 | CGGGGAAGGCGCCGGUGGGAGGCAAGGCACGGAUGGACUUUACCUGCGC… | 459 nt | 0.5577 |
| lnc-FOXD4L5-25:9 | GCACAGUGGUGGCCACCGCGACUGGUGCUGAAGUGUUGGCGCGUGCCGG… | 1091 nt | 0.4830 |
No relevant information is available at the moment.
A study in human patients identified the lnc-FOXD4L5-25 as a long non-coding RNA that was upregulated in heart failure compared to myocardial fibrosis [Wang et al. DOI:10.3389/fcvm.2021.664044].